Sun Pharma receives USFDA approval for cancer drug

05 May 2011 Evaluate

Sun Pharmaceutical Industries has received US health regulator’s approval for generic docetaxel injection, used in treating cancer, in the American market. The company’s subsidiary - Sun Pharma Advanced Research Company - has received abbreviated new drug approval from US Food and Drug Administration for Docefrez in strength of 20 mg/vial and 80 mg/vial. The company’s product is indicated for metastatic breast cancer, lung cancer and hormone refractory metastatic prostate cancer. This product could potentially give the company over $50 million over a year.

crackcrack

Sun Pharma Inds. Share Price

1687.55 35.45 (2.15%)
11-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1687.55
Dr. Reddys Lab 1109.15
Cipla 1463.15
Lupin 1969.05
Zydus Lifesciences 868.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...